Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
52-week open-label extension study of pitavastatin in children and adolescents with high-risk hyperlipidaemia
NL-OMON37642Phase 3Active, not recruiting
- Sponsor
- Kowa Company, Ltd.
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of pitavastatin in hyperlipidemia, sponsored by Kowa Company, Ltd. Primary endpoints: Adverse events, Clinical laboratory parameters and 3 more. Started Jul 2012; status: active, not recruiting.
02
Drugs
pitavastatin
03
Conditions
hyperlipidemia
Beyond the preview
Go deeper on NL-OMON37642.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON37642.